BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2021
View Archived Issues
Merck & Co. identifies compounds for treating herpes virus infection
Read More
Nuclear receptor ROR-gamma modulators discovered at Nuevolution
Read More
ARKUDA Therapeutics describes new progranulin modulators
Read More
AbbVie, Calico Life Sciences patent PROTACs targeting PTPN1 and/or PTPN2
Read More
Guangdong Feipeng Pharmaceutical presents anti-PD-1 antibodies
Read More
Nascent and Manhattan BioSolutions present preliminary data for BCG-based COVID-19 vaccine
Read More
Serum miR-146a is elevated in patients with COVID-19
Read More
FDA accepts IND application for phase I/II study of ExoFlo in ARDS
Read More
Blue Water Vaccines licenses novel VLP vaccine platform from Cincinnati Children's
Read More
GLPG-3970 shows clinical activity in early phase clinical trials
Read More
Positive topline data from phase Ib study of GLPG-3667 in psoriasis
Read More
Serum HBD2 is a marker of chronic spontaneous urticaria
Read More
First patient dosed in global phase I study of TST-005
Read More
Tumor suppressor p53 is inactivated by lncRNA
Read More
Novel PIV5-based mucosal vaccine protects mice and ferrets against SARS-CoV-2 challenge
Read More
IL-1alpha inhibition reduces hyperinflammation in a COVID-19 murine model
Read More
H3Mab-17 significantly reduces tumor growth in mouse model of colorectal adenocarcinoma
Read More
KRIBB-11 controls molecular pathways with potential for therapeutic strategy for glioblastoma
Read More
Phase II trial evaluates combination of VIR-2218 and VIR-3434 for chronic hepatitis B
Read More
BetterLife's AP-003 shows in vitro antiviral activity against SARS-CoV-2
Read More
Dosing underway in phase I study of IBI-319 in advanced malignant tumors
Read More
Compugen studies COM-902 in combination with COM-701 for advanced malignancies in phase I
Read More
Synlogic begins phase I study of SYNB-1934 for phenylketonuria
Read More
NCCN announces funded research projects to evaluate neratinib in cancer
Read More
Covimro shows in vivo efficacy in murine model of influenza A H3N2 infection
Read More
